Glutamate decarboxylase65-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain

Journal of Chemical Neuroanatomy

Volumn 20, Issue 3-4, 2000, Pages 259-269

  Benes, Francine M ^a   Todtenkopf, Mark S ^b   Logiotatos, Panagiota ^b   Williams, Mark ^b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Anterior cingulate; GABA cells; Interneurons; Neuroleptics

Indexed keywords

GLUTAMATE DECARBOXYLASE; NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; BRAIN REGION; CELL COUNT; CELL DENSITY; CELL SIZE; CINGULATE GYRUS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GABAERGIC TRANSMISSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; NEUROPIL; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SCHIZOPHRENIA;

ADULT; AGED; ANTIBODIES; BIPOLAR DISORDER; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; GYRUS CINGULI; HUMANS; INTERNEURONS; ISOENZYMES; MALE; MIDDLE AGED; PREFRONTAL CORTEX; PRESYNAPTIC TERMINALS; PYRAMIDAL CELLS; SCHIZOPHRENIA;

EID: 0034467350     PISSN: 08910618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-0618(00)00105-8     Document Type: Article

References (39)

1. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics
2. Stereotoxic anterior cingulotomy for neuropsychiatric illness and intractable pain
3. Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics
4. Microscopic findings in the cortex and hippocampus of schizophrenic and schizoaffective patients
5. Is there evidence for neuronal loss in schizophrenia?
6. Biochemical and morphometric studies of the relationship of actylcholine synthesis and vesicle numbers after stimulation of frog neuromuscular junctions: The effect of a choline-o-acetyltransferase inhibitor
7. A receptor binding in the hippocampal formation of schizophrenic brain
8. Two dimensional versus three dimensional cell counting: A practical perspective
9. Deficits in small interneurons in prefrontal and anterior cingulate cortex of schizophrenic and schizoaffective patients
10. Increased GABA-A receptor binding in superficial layers of cingulate cortex in schizophrenics
11. A receptor binding on neurons of prefrontal cortex in schizophrenic subjects
12. A and benzodiazepine receptor binding activity in the hippocampal formation of schizophrenic brain
13. Increased dopamine concentration in limbic areas of brain from patients dying with schizophrenia
14. Local circuit neurons immunoreactive for calretinin, calbindin D-28K or parvalbumin in monkey prefrontal cortex: Distribution and morphology
15. Local circuit neurons of the prefrontal cortex in schizophrenia: Selective increase in the density of calbindin-immunoreactive neurons
16. A receptors in schizophrenia: Studies on the human dorsolateral pref ronl cortex
17. Subgenual pref rontal cortex abnormalities in mood disorders
18. Diagnostic criteria for use in psychiatric research
19. 67) expression in schizophrenia and bipolar disorder
20. Calcium-binding proteins define subpopulations of interneurons in cingulate cortex
21. Basket cells
22. Two forms of the gamma-aminocutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions
23. Altered distribution of parval bumin-immunoreactive local circuit neurons in the anterior angulate cortex of schizophrenic patients
24. Glial reductions in the subgenual prefrontal cortex in mood disorders
25. Gamma-aminobutyric acid deficiency in brains of schizophrenic patients
26. Low plasma GABA is a trait-like marker for bipolar illness
27. The place of anticonvulsant therapy in bipolar illness
28. Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia
29. Abnormally high neuronal density in the schizophrenic cortex: A morphometric analysis of prefrontal area 9 and occipital area 17
30. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: Application of a 3-dimensional stereologic counting method
31. Reduced GABA uptake sites in the temporal lobe in schizophrenia
32. 65 transcripts in the rat hippocampus. A double in situ hybrdization study
33. 65-immunoreactive puncta on pyramidal and nonpyramidal neurons in hippocampus of schizophrenic brain
34. GABAj and brain abnormalities in schizophrenia
35. The effects of chronic haloperidol administration on GABA-immunoreactive axon terminals in rat medial prefrontal cortex
36. A comparison of the density of pyramidal (PN) and nonpyramidal (NP) neurons in the anterior cingulate cortex (ACCx) of schizophrenics (SZ) and manic depressives (MD)
37. Elementary introduction to stereological principles
38. A subclass of prefrontal γ-aminobutyric acid axon terminals are selectively altered in schizophrenia
39. Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons